Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission.
Erika
E
Kusajima
Masashi
M
Akiyama
Megumi
M
Sato
Ken
K
Natsuga
Hiroshi
H
Shimizu
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood; D001324:Autoantigens / Q000276:immunology*; D001379:Azathioprine / Q000627:therapeutic use; D015331:Cohort Studies; D003879:Dermatologic Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use; D024041:Non-Fibrillar Collagens / Q000276:immunology*; D010391:Pemphigoid, Bullous / Q000188:drug therapy* / Q000276:immunology*; D011239:Prednisolone / Q000627:therapeutic use; D012074:Remission Induction; D012720:Severity of Illness Index; D013752:Tetracycline / Q000627:therapeutic use; D016896:Treatment Outcome; D000097805:Collagen Type XVII
D001323:Autoantibodies; D001324:Autoantigens; D001379:Azathioprine; D003879:Dermatologic Agents; D009536:Niacinamide; D024041:Non-Fibrillar Collagens; D011239:Prednisolone; D013752:Tetracycline; D000097805:Collagen Type XVII